HCC Pharm ApS: Financial statements 2024
CVR: 41029013
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HCC Pharm ApS (CVR 41029013) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 65,623 and a net result of DKK 21,488 compared with DKK -4,274 the year before. That is an increase of 131.6% compared with the year before. Equity in the 2024 report amounted to DKK -68,599.
- Gross Profit
- DKK 65,623
- Profit/Loss
- DKK 21,488
- Equity
- DKK -68,599
- Total Assets
- DKK 580,819
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 66K | 21K | -69K | - |
| 2023 | - | 28K | -4K | -90K | 1 |
| 2022 | - | 29K | -13K | -86K | 1 |
| 2021 | - | 18K | -25K | -72K | 1 |
| 2020 | - | -63K | -88K | -48K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HCC Pharm ApS has published its annual report for 2023. Gross profit came to DKK 28,329, and the net result was DKK -4,274.
About HCC Pharm ApS
HCC Pharm ApS is a Danish company of the type Anpartsselskab based in Haarby, founded in 2019. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Hartmuth Hermann Walter Kleiß. The company is owned by Hartmuth Hermann Walter Kleiß. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 21,630 and a net result of DKK -19,646 compared with DKK 21,488 the year before. Equity in the 2025 report amounted to DKK -88,244.